← Eichor
Study identifier: NCT06170541 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CORE-COMPARE Pilot Study

Condition: Coronary Heart Disease (CHD)  ·  Sponsor: Johns Hopkins University

PhaseNA
Planned participants140
Who can joinAll sexes, 21 Years to 85 Years
Healthy volunteersNo

About this study

The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population) remains uncertain but is an important area of study in order to justify wider spread implementation and use of this technology, particularly in light of reports of significantly higher radiation exposure with UHR-CT, as well as longer scan times. The availability of technology to reconstruct conventional resolution (CR) simulation images from the raw CT acquisition data acquired on the UHR-CT scanner offers a unique platform to study this question without subjecting individuals to two different scans. The primary objective of this study is to generate preliminary data in support of the hypothesis that noninvasive UHR-CT is superior to conventional resolution CT for identifying patients with obstructive CHD.

This description comes directly from the study's public registry record.

Talk to the study team

Joao Lima, Professor  ·  4106141284  ·  jlima@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins School of MedicineBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06170541